USPSTF: Evidence Lacking to Recommend Full-body Skin Cancer Screens

USPSTF: Evidence Lacking to Recommend Skin Cancer Screens
USPSTF: Evidence Lacking to Recommend Skin Cancer Screens

(HealthDay News) -- There is insufficient evidence to recommend regular full-body exams for skin cancer as a means of preventing deaths from these cancers, according to a new review and recommendation statement published in the July 26 issue of the Journal of the American Medical Association.

The new report doesn't change the Task Force's prior statement on skin cancer screening issued in 2009. This latest update is "an explicit call for more evidence," David Grossman, M.D., M.P.H., vice-chairperson of the U.S. Preventive Services Task Force, told HealthDay, adding that very little new research has surfaced on either the benefits or the harms of screening for skin cancer during the past seven years.

Continue Reading Below

The largest recent study involved more than 360,000 people in northern Germany who received regular skin screening as well as education on sun protection, Grossman said. That study showed a nearly 50 percent decline in mortality rates from melanoma in men, and improved melanoma mortality rates compared with other nearby regions. "It's unclear whether the drop they saw in mortality is related to the screening or to improved behavioral response, with people using skin protection," Grossman said. In addition, "that rate wasn't sustained over time," he said. "If we saw a number of studies like this and they all were consistent and sustained, we would consider such evidence."

In an accompanying editorial, dermatologist Martin Weinstock, M.D., Ph.D., of Brown University's Warren Alpert Medical School in Providence, R.I., argued that "insufficient evidence of benefit" doesn't mean the same thing as "evidence of no benefit." The largest benefit of regular skin exams would be catching a melanoma before it became invasive. "The worst risk would be unnecessary biopsies that could lead to scarring of a person's skin and greater health care costs," he told HealthDay.

Recommendation Statement
Evidence Report
Editorial

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs